AZD9150 is a second-generation antisense oligonucleotide targeting the 3′-untranslated region (3′-UTR) of the STAT3 gene with reduction in STAT3 expression noted in a variety of preclinical cancer models [220,221,222]. Here, STAT3 is linked to cancer.